Back to top

Neuromuscular Diseases

We use pioneering treatments and treat all neuromuscular diseases, particularly Duchenne muscular dystrophy and spinal muscular atrophy

The Neuromuscular Diseases (NMD) Unit at SJD Barcelona Children’s Hospital is made up of a multidisciplinary team with experience in diagnosing, treating and researching the different pathologies within the sphere of NMDs. Our unit, linked to the Neurology Department, has CSUR accreditation (Reference Centres, Services and Units) in Spain and forms part of the EURO-NMD European Reference Network.

We are pioneers in the treatment of patients with Duchenne muscular dystrophy and spinal muscular atrophy, among other diseases. We collaborate with organisations and centres all over the world and we have developed an ambitious research programme focused on patient and family care.

There are more than 150 neuromuscular diseases, the majority of which are genetic and whose main characteristic is the progressive loss of muscle strength. These are chronic diseases, generally minority or rare, which impede comprehensive development in children, causing them to lose independence.

Treatments currently exist that delay the complications and progression of these diseases for which there is currently no cure. Our hospital takes part in clinical trials and research aimed at understanding the origin of these diseases and developing new, more effective therapies.

At SJD Barcelona Children’s Hospital, each case is analysed by a large team to provide the best possible treatment and improve the quality of life of our patients. We also provide psychological care and work closely with associations and families to alleviate the psychosocial burden of this type of disease. 

The quality of family care, as well as highly-specialised treatment and psychosocial support are what make us a leading hospital.

Neuromuscular Diseases Unit's activity

Hereditary neuropathies
47 %
genetically confirmed
International clinical trials
4
in progress
More than
900
patients treated a year NMD
Share